Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shohei Fukuda
Institution:
Institute of Science Tokyo
Observed institutions:
Tokyo Medical and Dental University,
IRCCS Ospedale San Raffaele,
IRCCS San Raffaele Roma,
Institute of Science Tokyo
ORCID:
0000-0003-2741-8338
Observed ORCID:
0000-0003-2741-8338
OpenAlex ID:
A5113177809
Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell Carcinoma
2024
·
Hajime Tanaka
, Yuki Fukawa
, et al.
·
Modern Pathology
·
9
PDF
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time‐Varying Effects
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
3
Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison
2025
·
Wei Chen
, Soichiro Yoshida
, et al.
·
Frontiers in Oncology
·
3
PDF
A case of double‐negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab
2024
·
Hiroki Tanaka
, Soichiro Yoshida
, et al.
·
IJU Case Reports
·
3
PDF
Impact of Approach Routes in MRI –Ultrasound Fusion Prostate Biopsy on Post‐Biopsy Complications: A Propensity Score‐Matched Analysis
2025
·
Hiroki Tanaka
, Masaki Kobayashi
, et al.
·
International Journal of Urology
·
2
PDF
Racial disparity in preoperative C‐reactive protein level for predicting prognosis of patients with non‐metastatic clear cell renal cell carcinoma: INMARC study
2025
·
Wei Chen
, Hajime Tanaka
, et al.
·
International Journal of Urology
·
2
PDF
Lymphocyte to C-reactive protein ratio and improved prognostication of renal cell carcinoma: machine learning-based analysis
2026
·
Melis Guer
, Cesare Saitta
, et al.
·
Frontiers in Oncology
PDF
Mixed Response to Nivolumab Among Different Metastatic Sites in Patients With Metastatic Renal Cell Carcinoma: Incidence and Clinical Implications
2026
·
Yudai Ishikawa
, Hajime Tanaka
, et al.
·
International Journal of Urology
Durable Disease Control With Nivolumab in Malignant Epithelioid Angiomyolipoma: A Case Report
2026
·
Hiroki Shimoda
, Shohei Fukuda
, et al.
·
IJU Case Reports
Predictive Value of Elevated Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Determining Adverse Pathology and Prognosis in Non-metastatic Renal Cell Carcinoma
2025
·
Giacomo Musso
, Margaret Meagher
, et al.
·
Urologic Oncology Seminars and Original Investigations
Mp10-09 Differential Impact of Positive Surgical Margin in High-risk Localized Renal Cell Carcinoma After Adjuvant and Neoadjuvant Systemic Therapy: a Multicenter Analysis
2024
·
Cesare Saitta
, Margaret F. Meagher
, et al.
·
The Journal of Urology
PDF
Mp36-10 Unraveling the “obesity Paradox” in Renal Cortical Tumors: Insights From the Inmarc Registry
2024
·
Cesare Saitta
, Jonathan A. Afari
, et al.
·
The Journal of Urology
PDF
Development of a Novel Nomogram to Predict Benign Lesion Pathology in Patients Affected by Renal Masses: Analysis of the Inmarc Registry.
2024
·
Jonathan A. Afari
, Cesare Saitta
, et al.
·
Urologic Oncology Seminars and Original Investigations
Show more works
View as search
Works count:
13
Citation count:
22
H-index:
3
I10-index:
Year
Topic
Type